SUPERSTRING CAPITAL MANAGEMENT LP
CIK: 0001931118Latest portfolio: $186.8M · Q4 2025
Holdings
45
Total Value
$186.8M
New Positions
29
Closed Positions
19
Top Holdings
View All 45 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | CDTXCIDARA THERAPEUTICS INC | 85,098 | $18.8M | 10.06% | +17K | |
| 2 | TERNTERNS PHARMACEUTICALS INC | 443,777 | $17.9M | 9.60% | -345,869 | |
| 3 | URGNUROGEN PHARMA LTD | 718,354 | $16.8M | 9.01% | +630K | |
| 4 | COGTCOGENT BIOSCIENCES INC | 366,238 | $13.0M | 6.96% | +5K | |
| 5 | DVAXDYNAVAX TECHNOLOGIES CORP | 525,592 | $8.1M | 4.33% | NEW | |
| 6 | SIONSIONNA THERAPEUTICS INC | 180,593 | $7.4M | 3.98% | NEW | |
| 7 | IMVTIMMUNOVANT INC | 288,677 | $7.3M | 3.93% | -52,671 | |
| 8 | AXSMAXSOME THERAPEUTICS INC | 37,433 | $6.8M | 3.66% | NEW | |
| 9 | YB4PSAVARA INC | 995,353 | $6.0M | 3.21% | -313,883 | |
| 10 | BRD1EURMIND MEDICINE MINDMED INC | 425,202 | $5.7M | 3.05% | NEW | |
| 11 | TSHATAYSHA GENE THERAPIES INC | 980,768 | $5.4M | 2.89% | NEW | |
| 12 | OCULOCULAR THERAPEUTIX INC | 418,080 | $5.1M | 2.72% | NEW | |
| 13 | AM6AMICUS THERAPEUTICS INC | 352,896 | $5.0M | 2.69% | NEW | |
| 14 | CABACABALETTA BIO INC | 2,253,550 | $4.9M | 2.64% | +709K | |
| 15 | UTHUNITED THERAPEUTICS CORP DEL | 9,451 | $4.6M | 2.47% | NEW | |
| 16 | RVMDREVOLUTION MEDICINES INC | 54,879 | $4.4M | 2.34% | NEW | |
| 17 | BLTEBELITE BIO INC | 24,703 | $4.0M | 2.12% | NEW | |
| 18 | DRUGBRIGHT MINDS BIOSCIENCES INC | 47,278 | $3.7M | 1.98% | -6,672 | |
| 19 | ZLABZAI LAB LTD | 196,853 | $3.5M | 1.86% | -3,775 | |
| 20 | ZBIOZENAS BIOPHARMA INC | 83,353 | $3.0M | 1.62% | -13,312 | |
| 21 | QNCXQUINCE THERAPEUTICS INC | 858,711 | $2.9M | 1.54% | NEW | |
| 22 | AVTXAVALO THERAPEUTICS INC | 153,313 | $2.8M | 1.49% | -34,767 | |
| 23 | CAPRCAPRICOR THERAPEUTICS INC | 96,334 | $2.8M | 1.49% | NEW | |
| 24 | PVLAPALVELLA THERAPEUTICS INC NE | 25,469 | $2.7M | 1.43% | NEW | |
| 25 | TCE2CELLDEX THERAPEUTICS INC NEW | 88,308 | $2.4M | 1.28% | NEW |
Quarterly Changes
New Positions
Sector Breakdown
Healthcare0.0% ($1.792816823130088e+136T)
Unknown0.0% ($1879760015693502.5T)
Technology0.0% ($33K)
Filing History
Fund Information
SUPERSTRING CAPITAL MANAGEMENT LP is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $186.8M across 45 holdings. The largest position is CIDARA THERAPEUTICS INC (CDTX), representing 10.1% of the portfolio. Compared to the previous quarter, the fund opened 29 new positions and closed 19 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.